| |
Symptoms onset* |
p value |
Symptoms duration † |
p value |
HPA axis recovery* |
p value |
| Ritonavir discontinued, HR (CI 95%) |
1.3 (0.3-5.2) |
0.7 |
0.2 (0.01-6.0) |
0.4 |
18.6 (2.4-145.9) |
<0.01 |
| Use of more than 100mg of Ritonavir, HR (CI 95%) |
0.6 (0.2-1.7) |
0.3 |
4.2 (0.3-52.5) |
0.3 |
0.2 (0.04-0.9) |
0.04 |
| Triamcinolone dose (continue, mg), HR (CI 95%) |
1.3 (0.3-5.2) |
0.2 |
0.9 (0.9-1) |
0.1 |
0.9 (0.9-1) |
0.03 |
Discontinuation of ritonavir is considered as a time dependant variable (time between triamcinolone injection and the discontinuation of ritonavir vary for all cases).
*Expressed in weeks, estimated from last injection day of triamcinolone; † expressed in weeks, estimated from first symptom onset. CI 95%: 95% confidence interval; HR:
hazard ratio |
